Empresa Galena Biopharma Inc Nasdaq
Acciones
US3632565046
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Angelos Stergiou
FOU | Founder | 48 | 03/04/06 |
John Burns
DFI | Director of Finance/CFO | 39 | 01/05/13 |
Andrew Elnatan
LAW | General Counsel | - | 05/01/23 |
Dragan Cicic
PRN | Corporate Officer/Principal | 60 | 10/02/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 67 | 29/12/17 | |
David Scheinberg
BRD | Director/Board Member | 68 | 01/12/17 |
John Varian
BRD | Director/Board Member | 64 | 29/12/17 |
Jane Wasman
CHM | Chairman | 67 | 29/12/17 |
Angelos Stergiou
FOU | Founder | 48 | 03/04/06 |
Katherine Kalin
BRD | Director/Board Member | 61 | 13/08/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 57 754 928 | 57 598 688 ( 99,73 %) | 0 | 99,73 % |
Información de la empresa
SELLAS Life Sciences Group, Inc.
Times Square Tower 7 Times Square
10026, New York
+
http://www.sellaslifesciences.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+2,96 % | 108 mil M | |
+10,36 % | 105 mil M | |
+1,57 % | 23,46 mil M | |
-12,24 % | 21,72 mil M | |
-7,05 % | 18,64 mil M | |
-37,64 % | 17,45 mil M | |
-6,81 % | 17,19 mil M | |
+6,37 % | 13,99 mil M | |
+37,01 % | 12,53 mil M |